Key result
Metabolic bone diseases independently accelerate cardiac valve calcification beyond traditional cardiovascular risks.
Why the study?
Epidemiological and clinical data suggested a link between cardiovascular and metabolic bone diseases, with valve calcification sharing similarities with bone osteogenesis. This review synthesized available data to better understand the relationship between osteoporosis or other metabolic bone diseases and valvular calcification.
Is metabolic bone disease associated with cardiac valve calcification?
Systematic Review
Is metabolic bone disease associated with cardiac valve calcification?
Osteoporosis and osteopenia appear to be independent risk factors for cardiac valve calcification, suggesting a shared biological mechanism between bone metabolism and valvular calcification.
Answers are grounded in this paper and cite their sources.
May inform valvular risk assessment in metabolic bone disease; supports independent association beyond traditional risks.
Epidemiological and clinical data have suggested the existence of a relationship between cardiovascular diseases and metabolic bone disease. Several studies have demonstrated that heart valve calcification presents substantial similarities with that of bone. Literature data indicate that there are many active processes which promote osteogenesis and loss of mineralization inhibitors that lead to the deposition of extracellular matrix and proteins of bone tissue in cardiac valves. This review aimed to synthesize the available data in order to allow a better understanding of the relationship between osteoporosis or other metabolic bone diseases, such as primary hyperparathyroidism, and valvular calcification in humans. Electronic databases of Pubmed-Medline, Cochrane Library, and SCOPUS from inception to March 31, 2019 were searched. The full set of the articles potentially eligible were carefully assessed and reviewed. Finally, 23 studies were eligible and included in the systematic review. The majority of studies reported that osteoporosis and/or osteopenia were independent risk factors for valvular calcifications, even after adjusting for common cardiovascular risk factors. This suggests that this relationship is not only due to the presence of common cardiovascular risk factors but rather to underlying biological factors that connect them. Instead, regarding the association between primary hyperparathyroidism and valve calcification, conflicting data were found in the literature. To sum up, most of the literature data confirm that cardiac valve calcification processes are strongly influenced by alterations in bone metabolism. In particular, the patients with osteoporosis or primary hyperparathyroidism have an acceleration in the process of valvular calcification. Additional studies are needed to specifically address the mechanisms by which metabolic bone diseases could influence cardiac valve calcification.
No takes yet. Share an insight, caveat, or question.
Carrai et al. (2020) conducted a systematic review in Metabolic bone disease (Osteoporosis, Primary Hyperparathyroidism). Metabolic bone disease (Osteoporosis, Osteopenia, Primary Hyperparathyroidism) vs. Normal bone metabolism / absence of disease was evaluated on Cardiac valve calcification (aortic or mitral). Osteoporosis, osteopenia, and primary hyperparathyroidism act as independent risk factors for cardiac valve calcification, accelerating the calcification process even after adjusting for traditional cardiovascular risks.
Synapse has enriched 10 related papers. Consider them for comparative context: